Tactile Systems Technology Inc (TCMD)
13.33
-1.75
(-11.60%)
USD |
NASDAQ |
Nov 05, 11:23
Tactile Systems Technology Research and Development Expense (Annual): 7.823M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 7.823M |
| December 31, 2022 | 7.088M |
| December 31, 2021 | 5.659M |
| December 31, 2020 | 5.264M |
| December 31, 2019 | 5.174M |
| December 31, 2018 | 5.289M |
| Date | Value |
|---|---|
| December 31, 2017 | 5.06M |
| December 31, 2016 | 4.476M |
| December 31, 2015 | 4.312M |
| December 31, 2014 | 2.843M |
| December 31, 2013 | 2.443M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
5.174M
Minimum
2019
7.823M
Maximum
2023
6.202M
Average
5.659M
Median
2021
Research and Development Expense (Annual) Benchmarks
| InfuSystems Holdings Inc | -- |
| Perspective Therapeutics Inc | 21.31M |
| Retractable Technologies Inc | 0.5812M |
| Xtant Medical Holdings Inc | 1.336M |
| Catheter Precision Inc | 0.475M |